New York, NY -- (SBWIRE) -- 12/30/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Novavax, Inc.(NASDAQ:NVAX), MGIC Investment Corp.(NYSE:MTG), Geron Corporation(NASDAQ:GERN), CYS Investments Inc(NYSE:CYS)
Novavax, Inc.(NASDAQ:NVAX) settled 0.00% at $5.13 on below -normal volume of 2,680,390shares during the last trading day. The stock has its 12-month high at $5.45and 52-week low price was $1.68. It traded in a range of $5.02 to $5.19 during the last trading day.Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases.
Can Investors Bet on NVAX after this News update? Find out in this Research Report
In the last trading session, MGIC Investment Corp.(NYSE:MTG) was downon low volume, trading at a volume of 2,621,885 shares versus its average daily volume of 5.30million shares. At $8.40, the stock has attained market capitalization of $2.84billion whereas its outstanding shares are 337.76 million.MGIC Investment Corporation, through its subsidiaries, provides mortgage insurance to lenders and government sponsored entities in the United States. T
How Should Investors Trade MTG Now? Don’t Miss out a Special Trend Analysis
GeronCorporation(NASDAQ:GERN) managed to keep its fall at 5.10% on above-normal volume of 2,598,494 shares. The stock settled at $4.84after floating in a range of $4.83 to $5.08. At its latest price, the stock reached market capitalization of $624.20 Million. Its 52-week range has been $0.98 to $7.79.Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
How Should Investors Trade GERNNow? Don’t Miss out a Special Trend Analysis
CYS Investments Inc(NYSE:CYS) traded down on a volume of 2,600,154 shares , lower than its standard daily volume. Shares have dropped1.46% to $7.43. Over the last twelve months, the stock has lost36.98% and faced a worst price of $6.74.CYS Investments, Inc., a specialty finance company, invests in residential mortgage pass-through certificates in the United States.
Is CYSa Solid Investment at These Levels? Read This Report For Details
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)